-
expand
Description of the use of Quetiapine Extended Release (XR) in real-life practice in France.
- Disease
- bipolar disorder, schizophrenia
- Drug Name
- non drug study (neuroscience)
- Study Name
- NIS-NFR-SER-2012/1
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Multinational, Multicenter, Retrospective, Observational Drug Utilisation Study of Seroquel® Extended Release (XR) Prescribed by Psychiatrists as Treatment for Major Depressive Disorder (MDD) in Selected Countries in the European Union (EU).
- Study Id
- D1443C00057
- Disease
- depressive disorder
- Drug Name
- non drug study (neuroscience)
- Study Name
- EUDUS
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A 6-month, Multicenter, Open-label, Safety Study of VIMOVO (250 mg/20 mg, 375 mg/20 mg, and 500 mg/20 mg Naproxen/Esomeprazole) in Adolescents Aged 12 to 16 Years, Inclusive, with Juvenile Idiopathic Arthritis (JIA).
- Study Id
- D1120C00037
- Disease
- arthritis
- Drug Name
- neuroscience agents
- Study Name
- D1120C00037
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 Including an Open-Label Food Effect Group in Healthy Male and Non-Fertile Female Volunteers.
- Study Id
- D5010C00001
- Disease
- clinical pharmacodynamics, clinical pharmacokinetics
- Drug Name
- AstraZeneca Neuroscience Development Drugs
- Study Name
- D5010C00001
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase 2a Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects with Moderate to Severe Crohn’s Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy.
- Study Id
- D5170C00001
- Disease
- Crohn's disease
- Drug Name
- AstraZeneca Gastrointestinal Development Drugs
- Study Name
- D5170C00001
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
An Open-Label, Randomized, Multicenter, Phase III Study of Ceftazidime Avibactam (CAZ-AVI, formerly CAZ104) and Best Available Therapy for the Treatment of Infections Due to Ceftazidime Resistant Gram Negative Pathogens
- Study Id
- D4280C00006
- Disease
- bacterial infection, infectious diseases
- Drug Name
- CAZ-104
- Study Name
- D4280C00006
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Perception of symptom variability in Chinese COPD patients
- Study Id
- NIS-RCN-XXX-2012/1
- Disease
- chronic obstructive pulmonary disease
- Drug Name
- non drug study (respiratory)
- Study Name
- NIS-RCN-XXX-2012/1
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor versus Clopidogrel in African American Patients with Stable Coronary Artery Disease
- Study Id
- Brilinta (AZD6140)
- Disease
- coronary artery disease
- Drug Name
- AZD6140
- Study Name
- D5130L00013
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Randomized, Open-Label, Multiple Dose, Crossover, Multiple Center Study of the Antiplatelet Effects of Ticagrelor versus Clopidogrel in Hispanic Patients with Stable Coronary Artery Disease
- Study Id
- Brilinta (AZD6140)
- Disease
- coronary artery disease
- Drug Name
- AZD6140
- Study Name
- D5130L00012
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Prevalence of Gastroesophageal reflux disease (GERD) in patients with upper gastrointestinal tract symptoms in Egypt
- Study Id
- NIS-GEG-XXX-2012/1
- Disease
- gastroesophageal reflux disease
- Drug Name
- non drug study (gastrointestinal)
- Study Name
- NIS-GEG-XXX-2012/1
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
